Leukeran

Approved Uses

Leukeran is primarily prescribed to treat specific cancers of the blood and lymphatic system. It is most commonly used for the following conditions:

• Chronic lymphocytic leukemia (CLL): A type of cancer that begins in the white blood cells found in the bone marrow.
• Hodgkin's disease: A cancer of the immune system, also known as Hodgkin lymphoma.
• Non-Hodgkin's lymphomas: This includes specific types such as follicular lymphoma and lymphosarcoma.

This medication belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells in the body.

Treatment Goals

Leukeran is often used to provide palliation, which means it is intended to reduce the symptoms of the disease and improve quality of life. While it may not cure the cancer, it helps manage the progression of these conditions in many patients.

Mechanism of Action

Leukeran belongs to a class of medications known as alkylating agents. These drugs are specifically designed to target and interfere with the life cycle of cancer cells.

The medication works through the following process:

• DNA Interference: Once inside the body, Leukeran attaches to the DNA within cancer cells.
• Preventing Cell Division: By binding to the DNA, the drug prevents the cancer cells from duplicating their genetic material.
• Stopping Growth: Because the cells cannot copy their DNA, they are unable to divide and multiply into new cancer cells.

By disrupting this cycle, Leukeran helps to decrease the number of abnormal cells in the blood and lymph nodes. This process is used to manage conditions like chronic lymphocytic leukemia and certain types of lymphoma by slowing the progression of the disease.

Common Side Effects

Common side effects of Leukeran may include:

• Nausea and vomiting
• Diarrhea
• Mouth sores
• Missed menstrual periods

Serious Side Effects

Contact your doctor immediately if you experience any of the following serious side effects:

• Fever, chills, sore throat, or other signs of infection
• Unusual bruising or bleeding
• Shortness of breath or a persistent cough
• Yellowing of the skin or eyes (jaundice)
• Dark urine
• Severe skin rash, itching, or hives
• Swelling of the face, lips, or tongue
• Seizures, tremors, or muscle twitching
• Unusual lumps or masses

Leukeran can cause a significant decrease in blood cells produced by the bone marrow, which may increase the risk of infection, anemia, or bleeding problems. Long-term use is also associated with an increased risk of developing other cancers, such as leukemia, and may cause permanent infertility in both men and women.

Boxed Warnings

Leukeran carries several serious warnings due to its potency and potential for long-term effects:

• Bone Marrow Suppression: This medication can significantly lower the number of white blood cells, red blood cells, and platelets. This increases the risk of serious infections, anemia, and easy bruising or bleeding. Blood counts usually return to normal after stopping the drug, but suppression can be irreversible in some cases.
• Secondary Cancers: Chlorambucil is known to cause cancer in humans. Long-term use has been linked to the development of secondary cancers, such as acute leukemia.
• Reproductive Risks: This drug may cause permanent infertility in both men and women. It can also cause severe harm or death to an unborn baby if taken during pregnancy.

Other Precautions

Additional safety considerations include:

• Seizures: There is an increased risk of seizures, especially in children with certain kidney conditions or in individuals receiving high doses of the medication.
• Liver Function: Individuals with existing liver disease may require closer monitoring, as the drug is processed by the liver.
• Skin Reactions: Rare but serious skin reactions, such as Stevens-Johnson syndrome, have been reported.
• Vaccinations: Because the immune system is weakened, live vaccines are generally avoided while taking this medication.

Monitoring

Frequent blood tests are necessary to monitor blood cell levels and ensure the dosage remains safe. Treatment may be paused or adjusted if blood counts drop too low.

Pregnancy

Leukeran (chlorambucil) can cause significant harm to an unborn baby if taken during pregnancy. It is known to cause birth defects in humans. Individuals who can become pregnant should use effective birth control methods while taking this medication to prevent pregnancy. If a patient becomes pregnant while using this drug, they should contact their healthcare provider immediately to discuss the potential risks to the fetus.

Breastfeeding

It is not currently known if Leukeran passes into human breast milk. However, because of the potential for serious side effects in a nursing infant, breastfeeding is typically not recommended during treatment with this medication. Patients should discuss the risks and benefits of breastfeeding with their doctor.

Fertility

Leukeran may affect fertility in both men and women. In some cases, this medication can cause permanent infertility by interfering with the production of sperm or the normal menstrual cycle. Patients concerned about their future ability to have children should discuss these risks with a healthcare professional before starting treatment.

Dosage Forms

Leukeran is supplied as a film-coated tablet intended for oral administration. It is currently only available in this oral solid form.

FDA Approval and Indications

Leukeran (chlorambucil) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of cancer. Its primary indications include:

• Chronic lymphocytic leukemia
• Malignant lymphomas, such as lymphosarcoma and giant follicular lymphoma
• Hodgkin's disease

Boxed Warning

The FDA-approved labeling for Leukeran includes a boxed warning, which is the most serious type of warning issued by the FDA. This warning highlights several critical risks:

• Bone Marrow Suppression: The drug can cause severe and potentially permanent suppression of the bone marrow, leading to dangerously low levels of white blood cells, red blood cells, and platelets.
• Carcinogenicity: Long-term use of Leukeran has been linked to the development of secondary cancers, such as acute myelogenous leukemia.
• Infertility: The medication may cause permanent infertility in both men and women.
• Fetal Harm: Leukeran is known to cause birth defects and should not be used during pregnancy.

Regulatory Status and Availability

Leukeran is available as a brand-name drug and in generic formulations. Because of its potential for serious side effects, the FDA requires that it be administered under the supervision of a physician experienced in the use of cancer chemotherapy agents. There are currently no specific Risk Evaluation and Mitigation Strategy (REMS) programs required for this medication beyond the standard boxed warnings and professional supervision requirements.

Generic Availability

Leukeran is the brand name for the medication chlorambucil. A generic version of chlorambucil is available, and it usually costs significantly less than the brand-name drug. Most pharmacies stock the generic version.

Insurance Coverage

Most private insurance plans, as well as Medicare and Medicaid, provide coverage for chlorambucil. The out-of-pocket cost for the patient will depend on the specific insurance plan, including the deductible and the tier at which the drug is placed on the plan's formulary.

Factors Affecting Cost

The total price of Leukeran can be influenced by several factors:

• Pharmacy choice: Prices can vary between different retail pharmacies and mail-order services.
• Dosage: The strength and number of tablets prescribed will impact the overall cost.
• Assistance programs: Some patients may be eligible for financial assistance through manufacturer programs or non-profit organizations if they meet certain income requirements.